Telisotuzumab vedotin, CAS 1714088-51-3

Product Description: Telisotuzumab vedotin (ABBV-399) is an antibody-drug conjugate (ADCs) targeting c-Met. Telisotuzumab vedotin consists of Monomethyl Auristatin E (MMAE), Telisotuzumab antibody and a cleavable mc-val-cit-PABC type linker. Telisotuzumab vedotin can be used in cancer research[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Strickler JH, et al. First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors. J Clin Oncol. 2018 Nov 20;36(33):3298-3306.

CAS Number: 1714088-51-3

Molecular Weight: 145000 (average)

Compound Purity: 99.90

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Antibody-Drug Conjugates (ADCs);c-Met/HGFR

• Artikelnummer: MEXHY-141601-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-141601-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK